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CASE REPORT

ABSTRACT

Amniotic Fluid Embolism
Nadia Nawaz1 and Ahmed Raheem Buksh2

Amniotic fluid embolism is a rare and severe problem in obstetric patients. We experienced a 21-year primigravida who
underwent emergency cesarean section due to sudden collapse and fetal distress after rupture of membranes in labour.
Subsequently, she developed intraoperative coagulopathy, hemorrhage, hypotension, and respiratory collapse requiring
ventilation. Both maternal and neonatal lives were saved with full recovery and discharged in stable condition. The clinical
diagnosis of amniotic fluid embolism (AFE) was made, which is a very rare complication of pregnancy/puerperium with
varying presentation, ranging from cardiac arrest, circulatory collapse and death through mild degrees of organ system
dysfunction with or without coagulopathy. AFE has no definitive test for its diagnosis; the detection of fetal elements in the
maternal vasculature is non-specific. The treatment is largely supportive and there is no specific therapy. However,
mortality of this condition remains high, if not timely intervened.
Key Words: Amniotic fluid embolism. Cesarean section. Complication. Cardiac arrest.

INTRODUCTION

Despite its recognition as a distinct entity for almost 100
years, the syndrome commonly referred to as Amniotic
Fluid Embolism (AFE) remains one of the most
devastating conditions in obstetrics.1 AFE is a rare
condition and a lethal complication of pregnancy and
puerperium. Because of this very rarity, and the fact that
it is a diagnosis of exclusion, the true incidence is difficult
to determine. Combined with internationally differing
definitions of AFE as well as differing methodologies for
reporting and recording data, this results in a great range
of reported incidence rates between countries. The
International Network of Obstetric Survey Systems
(INOSS) has recently produced a consensus definition
of AFE as 'an acute cardio-respiratory collapse within 6
hours after labour, birth or ruptured membranes, with no
other identifiable cause, followed by acute coagulopathy
in those women who survive the initial event,' and has
recommended its use in future.2
Its presentation varies from cardiac or circulatory
shutdown to sudden death with varying degrees of
multiple organ dysfunction. Approximately 47% of
women who experience AFE have a prior sign or symptom
before collapse. Commonly reported premonitory
symptoms include tingling sensation or numbness,
agitation or breathlessness, lightheadedness, chest pain
or complain of feeling cold. Almost 36% of patients had
fetal compromise before any change in maternal
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condition, likely due to compensated or unrecognised
maternal hypoxia and hypotension. Cardiac arrest as a
presenting feature is recorded in 60-80% of registered
cases.2
AFE appears to involve an abnormal activation of
humoral and immunologic mechanisms leading to a
massive inflammatory reaction following the entry of
fetal cells (antigens) into the maternal circulation. 3 It is
largely a clinical "diagnosis of exclusion" and, therefore,
requires high level of suspicion. At present, there is no
any specific antemortem test for diagnosis of this
syndrome. It is commonly diagnosed retrospectively and
is primarily clinical diagnosis. Postmortem presence of
fetal debris or squamous cells in the maternal pulmonary
circulation remains a key diagnostic requirement, but is
not found in every case.

The management of pregnant women with suspicion of
AFE remains largely supportive and is directed at
reversing any observable physiological abnormalities,
with primary correction of oxygenation, coagulopathy
and circulatory support. Once the patient presents with
collapse, the basic principles of ABCd resuscitation
should apply, with "d" representing delivery of the fetus
in this case. A multidisciplinary team approach including
senior obstetricians, midwives, anaesthetists, critical
care team, intensivists, and haematologists is the key to
success. Several studies have now highlighted the
association between neonatal outcome and timing of
delivery in relation to the onset of AFE. The overall UK
perinatal mortality rate in AFE is reported as 67 per
1000. The morbidity of AFE for the baby is also reflected
in high rates of NICU admission, ventilation, encephalopathy, and long-term morbidity.2
The recurrence rate of AFE is unknown because of the
extremely low incidence and high mortality rate of the
condition. No cases of recurrence have been reported
in the literature, but many cases of straightforward
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subsequent pregnancies have been reported. So, whilst
patients can be reassured to some degree when
planning future pregnancies, they should also be
counselled that the available sample size does not allow
definitive conclusions regarding the risk of recurrence. 2
A recent, retrospective review by Dildy et al. found that
out of 105 women who had survived AFE, only 22% had
gone on to conceive again; and of those, who had not
conceived, 61% had chosen not to do so due to a fear of
recurrent AFE.

CASE REPORT

A 21-year healthy primigravida, height 163 cm, weighing
62 kgs, presented at 36 weeks of gestation in labour
room with rupture of membranes since morning and mild
labour pain. When received in our triage area, she was
well oriented and vitally stable (blood pressure 120/80
mmHg and pulse 82 bpm). Fetal heart beat at the time
of presentation was 140bpm and fetus showed a
reactive cardiotocograph. On vaginal examination, it
was 2 cm dilated, draining clear liquor.

Suddenly, patient had a generalised tonic-clonic fit with
upward rolling of eyes and frothing from mouth. Fit was
self-limiting, followed by sudden maternal collapse. She
became pulseless and no blood pressures were
recordable. Immediate cardiopulmonary resuscitation
(CPR) was initiated and patient intubated. She revived
but soon crashed again. A second episode of CPR was
started and patient revived. Simultaneously, on per
abdominal examination, there was sustained uterine
contraction and fetal heart beat showed bradycardia of
65 bpm, which necessitated the need for cesarean
section. Patient was rushed to operating room for
emergency cesarean section with continuous bagging;
and a limp baby boy of 2.9 kgs was born with an Apgar
score of 2/1 and 7/5 min. Baby was handed over to
pediatrician for resuscitation. The vital signs of the
patient in the operation room (OR) were 100/60 mmHg
of blood pressure, 150 bpm of heart rate, and 100% of
oxygen saturation on high ventilatory parameters. Her
arterial blood gases at the time of intubation were pH
6.78, PCO2O, 11.8, PO2 13, and O2 saturation 48%. She
was administered norepinephrine infusion at 0.15
µg/kg/min for hypotension intraoperatively. Intraoperatively, patient developed uterine atony and started
bleeding from uterine stitch line and developed
excessive oozing, secondary to disseminated intravascular coagulation (DIC). Further laboratory tests
were performed that showed the presence of severe
coagulopathy with values of prothrombin time (PT) >120
s (normal 10.5-13.5 s), activated partial thromboplastic
time (APTT) >120 s (normal: 21-36 s), INR >9.0,
D-dimer 3.3 mg/L (normal <0.2 mg/L) and fibrinogen, 0.5
g/dl (normal; 1.5-4.0 g/dl), fibrinogen degeneration
product (FDP) >20 µg/L (normal; 0-4 µg/L). Her platelet
count was initially 104 x 109/l. Massive transfusion protocol
S108

was initiated and a total of 6 packed cell volumes (PCV),
10 fresh frozen plasma (FFP), 10 platelet, and 6
cryoprecipitates were transfused intraoperatively, in the
immediate post-operative period. With immediate and
rapid blood products replacement, uterine atony and
bleeding from stitch line improved markedly and a
condom catheter uterine tamponade was inserted with
400 ml of distilled water and vagina was packed with 2
ribbon gauzes. The total duration of operation was 3
hours; the urinary output was 800 ml with 3000 ml of
blood loss. The fluid input was 2000 ml; and 3650 ml of
blood was transfused. Her chest radiography showed
increased hilar markings and possibility of pulmonary
edema.

Postoperatively, patient was shifted to intensive care unit
(ICU). Hemodynamic stability was achieved and her
urinary outputs were satisfactory after mild initial
hematuria. She remained in ICU for one day and was
extubated on 1st postoperative day. Transthoracic
echocardiography was performed which revealed
normal cardiac chambers, ejection fraction of 50%,
mildly reduced right ventricular systolic function, and
moderate tricuspid regurgitation. Next day, she was
shifted to special care unit. During ICU stay, MRI brain
was performed showing no evidence of posterior
reversible encephalopathy syndrome (PRES), cerebral
venous sinus thrombosis (CVST). No additional
significant abnormality was noted. CT did not
demonstrate a pulmonary embolism. A diagnosis of AFE
was made. Both baby and mother were discharged in
stable condition on 6th postoperative day. On 2 weeks
post-natal follow-up in clinic, both mother and baby were
healthy and stable. There were no observed neurological
sequelae as well.

DISCUSSION

AFE is notified among the five major causes of direct
maternal deaths in the UK with other including
eclampsia, pulmonary embolism, severe sepsis and
peripartum haemorrhage.4,5 It is a rare but devastating
complication of pregnancy with incidence of approximately
1 in 40,000 deliveries.1,3,6 The reported mortality rate of
the condition ranges from 20% to 60%.1,3 The diagnosis
of AFE is largely a "diagnosis of exclusion".3 Its
pathogenesis can be broadly classified into three
subtypes: (1) The mechanical obstruction subtype which is the actual embolization of the maternal
pulmonary vasculature,3 (2) The anaphylactic subtype in which there is anaphylactic reaction with idiosyncratic
adverse response and massive postpartum hemorrhage,
(3) The DIC subtype with a massive post-partum
haemorrhage. Each subtype has a separate pattern of
clinical signs and symptoms with varying severity of the
disease. Wide range of mortality and survival is affected
by the specific subtype.7-9
Management is largely supportive with an interdisciplinary team effort that comprises prompt and
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aggressive hemodynamic resuscitation including timely
fluid and blood component replacement with correcting
hemostatic disorders and provision of end-organ support
with timely delivery of the fetus to aid in resuccitation
and decreasing fetomaternal compromise.3

A team effort and multidisciplinary care can have
profound effect on the outcomes. For the past 10 years,
medical error and patient safety in the course of patient
care has gained significant attention. Obstetric
emergencies usually involve low risk and young patients
and require a very efficient chain of multidiciplinary team
effort to improve outcomes. A key to success is the
timely intervention, sometimes referred to as "The
Golden Hour" in the management. As in this case, timely
recognition of the collapse with urgent involvement of
the anesthesia team and cesarean delivery of the fetus
within 5 mins of CPR were the hallmarks.
To be more precise, a very well coordinated and timesensitive response to an obstetric emergency is required
for improving outcomes. The role of local training
programmes on individual basis in the management of
maternal collapse cannot be denied and are conducted
frequently. However, more recently, there has been a
huge debate on simulation training in obstetric
emergencies and the emerging results are worth it. It
involves training of a multiprofessional team involved in
the care rather than on individual basis and simulates an
emergency without any harm to real patients.

Few articles, evaluating the effect of teamwork training
with simulation models, have been published; and even
fewer have examined objective measurements of
improvement in the management of acute obstetric
emergencies.4 In a multicentre randomised clinical trial
in The Netherlands, they found a significant improvement
in team performance and a significant increase in the
use of new medical technical skills 8 months after
obstetric, multiprofessional team training in a medical
simulation centre.5

There is paucity in the literature on the role of effective
teamwork in the management of AFE owing to the rarity
of its occurence. However, some case reports have
been published internationally showing successful
outcomes with prompt detection and aggressive
management. A case reported in India in which a 27-year
primipara had AFE during the peripartum period, in
which due to expeditious CPR, both the mother and the
newborn survived.6
Many survivors do present with some degree of
neurological impairment. The rate of perinatal death with
AFE approximates 25%, and 50% of surviving neonates
are neurologically intact. A study in UK included women
with a diagnosis of AFE from February 2005 to January
2014. It concluded that for every one woman who dies

because of AFE, four survive. Among the surviving
women with AFE, 7% display permanent neurologic
injury. The women who survived with AFE without any
permanent neurologic injury, 17% had other major
morbidity.9 For counselling regarding subsequent
pregnancies, it is worth knowing that to date a total of 12
cases of successful pregnancy after survival from AFE
have been reported in the literature with no case of
recurrence of AFE.10 A retrospective case study in Japan,
including 10 AFE patients, showed a maternal mortality
rate of 70%.11
AFE is rare but potentially devastating syndrome that
manifests mainly during or around delivery. Immediate
resuscitation and interdisciplinary approach, with active
cardiopulmonary stabilization, hemodynamic correction,
early vasopressor use, correction of hemostatic
disorders and undelayed cesarean delivery, plays a
important role in the outcome.
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